NuCana PLC (NCNA.Q) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Acerlarin® (NUC-1031), which is currently being evaluated in a Phase…
Latest News
Top 5 Gainers and Losers: RPX.V, NINE.CN, DCBO.TO
Silver bulls maintain strong uptrend!
Top 5 Gainers and Losers: WIFI.CN, RAIL.CN, BHS.V
Standard Uranium (STND.V) begins inaugural drill program at Canary Project
Top 5 Gainers and Losers: SHOP.TO, MNO.TO, EFX.TO
Good Guy Wrap: Who’s moving up, who’s good value, who you should burn